109 related articles for article (PubMed ID: 20717823)
1. Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[¹⁸F]fluoro-17β-oestradiol PET.
Tsujikawa T; Yoshida Y; Kiyono Y; Kurokawa T; Kudo T; Fujibayashi Y; Kotsuji F; Okazawa H
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):37-45. PubMed ID: 20717823
[TBL] [Abstract][Full Text] [Related]
2. Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.
Fowler AM; Chan SR; Sharp TL; Fettig NM; Zhou D; Dence CS; Carlson KE; Jeyakumar M; Katzenellenbogen JA; Schreiber RD; Welch MJ
J Nucl Med; 2012 Jul; 53(7):1119-26. PubMed ID: 22669982
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy.
van Kruchten M; Glaudemans AWJM; de Vries EFJ; Schröder CP; de Vries EGE; Hospers GAP
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1674-1681. PubMed ID: 26091705
[TBL] [Abstract][Full Text] [Related]
4. Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[
Mankoff D; Balogová S; Dunnwald L; Dehdashti F; DeVries E; Evangelista L; Van Kruchten M; Vaz SC; Fowler A; Linden H; Ulaner GA
J Nucl Med; 2024 Feb; 65(2):221-223. PubMed ID: 38071554
[TBL] [Abstract][Full Text] [Related]
5. Prospective Pilot Study of
Covington MF; Hoffman JM; Morton KA; Buckway B; Boucher KM; Rosenthal RE; Porretta JM; Brownson KE; Matsen CB; Vaklavas C; Ward JH; Wei M; Buys SS; Chittoria N; Yakish ED; Archibald ZG; Burrell LD; Butterfield RI; Yap JT
AJR Am J Roentgenol; 2023 Aug; 221(2):228-239. PubMed ID: 36919879
[No Abstract] [Full Text] [Related]
6. A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC).
Peterson LM; Kurland BF; Schubert EK; Link JM; Gadi VK; Specht JM; Eary JF; Porter P; Shankar LK; Mankoff DA; Linden HM
Mol Imaging Biol; 2014 Jun; 16(3):431-40. PubMed ID: 24170452
[TBL] [Abstract][Full Text] [Related]
7. Head-to-head comparison of
Kiatkittikul P; Mayurasakorn S; Promteangtrong C; Kunawudhi A; Siripongsatian D; Hirata N; Jantarato A; Boonkawin N; Yaset S; Kongsakorn P; Phewnual W; Chotipanich C
Eur J Hybrid Imaging; 2023 Dec; 7(1):23. PubMed ID: 38105347
[TBL] [Abstract][Full Text] [Related]
8. Uterine Uptake of Estrogen and Progestogen-Based Radiotracers in Rhesus Macaques with Endometriosis.
Wilson RC; Link JM; Lee YZ; Oldan JD; Young SL; Slayden OD
Mol Imaging Biol; 2024 Apr; 26(2):334-343. PubMed ID: 38133866
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic Analysis of [
Ghazanfari N; Doorduin J; van der Weijden CWJ; Willemsen ATM; Glaudemans AWJM; van Waarde A; Dierckx RAJO; de Vries EFJ
Mol Imaging Biol; 2024 Apr; 26(2):351-359. PubMed ID: 38263484
[TBL] [Abstract][Full Text] [Related]
10. Fluorine-18-Labeled Fluoroestradiol PET/CT: Current Status, Gaps in Knowledge, and Controversies-AJR Expert Panel Narrative Review.
Covington MF; O'Brien SR; Lawhn-Heath C; Pantel AR; Ulaner GA; Linden HM; Dehdashti F
AJR Am J Roentgenol; 2023 Dec; ():. PubMed ID: 38117098
[TBL] [Abstract][Full Text] [Related]
11.
Grabher BJ
J Nucl Med Technol; 2023 Sep; 51(3):188-193. PubMed ID: 37433673
[TBL] [Abstract][Full Text] [Related]
12. Dynamic (18) F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts.
Kristian A; Nilsen LB; Røe K; Revheim ME; Engebråten O; Mælandsmo GM; Holm R; Malinen E; Seierstad T
Nucl Med Mol Imaging; 2013 Sep; 47(3):173-80. PubMed ID: 24900104
[TBL] [Abstract][Full Text] [Related]
13. Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging.
Bonaventura J; Boehm MA; Jedema HP; Solis O; Pignatelli M; Song X; Lu H; Richie CT; Zhang S; Gomez JL; Lam S; Morales M; Gharbawie OA; Pomper MG; Stein EA; Bradberry CW; Michaelides M
Sci Transl Med; 2023 Jul; 15(706):eadd1014. PubMed ID: 37494470
[TBL] [Abstract][Full Text] [Related]
14. Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers.
Berg A; Gulati A; Ytre-Hauge S; Fasmer KE; Mauland KK; Hoivik EA; Husby JA; Tangen IL; Trovik J; Halle MK; Stefansson I; Akslen LA; Woie K; Bjørge L; Salvesen HB; Salvesen ØO; Werner HMJ; Haldorsen IS; Krakstad C
Oncotarget; 2017 Sep; 8(40):68530-68541. PubMed ID: 28978135
[TBL] [Abstract][Full Text] [Related]
15. A metastatic, cutaneous mucinous carcinoma revealed by the 16α-
Longo R; Mammoud SB; Ribal R; Dadoun A; Egea J; Plastino F; Legros PO; Marcon N; Liegeon AL; Campitiello M
J Dermatol; 2024 Jan; ():. PubMed ID: 38216980
[No Abstract] [Full Text] [Related]
16. Prognostic Value of 16α-
Yamada S; Tsuyoshi H; Yamamoto M; Tsujikawa T; Kiyono Y; Okazawa H; Yoshida Y
J Nucl Med; 2021 May; 62(5):636-642. PubMed ID: 33008930
[TBL] [Abstract][Full Text] [Related]
17. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
Zhao Z; Yoshida Y; Kurokawa T; Kiyono Y; Mori T; Okazawa H
J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314
[TBL] [Abstract][Full Text] [Related]
18. Roles of estrogen receptor α in endometrial carcinoma (Review).
Ge Y; Ni X; Li J; Ye M; Jin X
Oncol Lett; 2023 Dec; 26(6):530. PubMed ID: 38020303
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Receptor Imaging In Vivo-Clinical and Research Advances.
Parent EE; Fowler AM
J Endocr Soc; 2023 Jan; 7(3):bvac197. PubMed ID: 36655003
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
